超微戊己丸治疗肝胃郁热型胃溃疡的临床效应及其炎症机理研究
|
摘要
目的:评价超微戊己丸对肝胃郁热型胃溃疡患者的临床疗效,并从炎症因子IL-6、IL-8以及TNF-a的表达探讨其抗Hp的作用。
方法:
1.按照中药新药临床研究要求,观察超微戊己丸对肝胃郁热型胃溃疡患者的临床疗效、胃镜检查、血清炎症因子IL-6、IL-8、TNF-a的影响。
2.采用Hp感染胃溃疡模型,随机分组,分别给药,分别采用ELASA、免疫组化检测IL-6、IL-8、TNF-a含量与表达
结果:
1.超微戊己丸对肝胃郁热型胃溃疡患者的临床疗效、中医证候疗效、胃镜疗效和Hp清除率分别为80.3%、90%、33.3%和66.7%,与传统戊己丸比较,差异无统计学意义(p>0.05)。
2.1/3剂量超微戊己丸能缩小HP感染致胃溃疡模型溃疡面积,与传统戊己丸全剂量组和三九胃泰组比较,差异无统计学意义(p>0.05),其能降低模型动物血清炎症因子IL-6、IL-8和TNF-a水平,下调TNF-a基因表达,与传统戊己丸、三九胃泰比较,差异无统计学意义(p>0.05)。
结论:
1.超微戊己丸能明显改善幽门螺杆菌致胃溃疡患者的临床症状,胃溃疡粘膜面积,调节血清炎症因子的水平,是较理想的针对肝胃郁热型胃溃疡的药物。
2.超微戊己丸能较好清除幽门螺杆菌致胃溃疡大鼠的幽门螺杆菌,明显下调IL-6、IL-8及TNF-a的表达。
Objective:To evaluate the clinical efficiency of ultra-podwer Wuji Pill on patients with gastric ulcer in syndrome of stomach and liver stagnation-hot,and discuss its effect on Anti-HP from expression of Inflammatory factors IL-6,IL-8 and TNF-a.
Methods:
1.According Chinese medicine clinical research in accordance with the requirements,evaluating the clinical efficiency,Gastroscopy result, Inflammatory factors IL-6,IL-8 and TNF-a of ultra-podwer Wuji Pill on patients with gastric ulcer in syndrome of stomach and liver stagnation-hot.
2.Using gastric ulcer model in Hp infection,animals were randomized, administrated respectively and detecting content and expression of IL-6,IL-8 and TNF-a by ELASA and Immunohistochemistry method.
Results:
1.Clinical efficiency,Syndrome efficiency,Gastroscopy effect and clearance rate of HP of ultra-podwer Wuji Pill on patients with gastric ulcer in syndrome of stomach and liver stagnation-hot was 80.3%.90%.33.3%and 66.7%,compared with traditional Wuji pill group,there was not significant difference(p＞0.05).
2.1/3 dosage ultra-podwer Wuji Pill group can narrow ulcer area of HP infected model,decrease expression of IL-6,IL-8 and TNF-a in rat model,which compared with traditional Wuji pill group and sanjiu weitai group,there was not significant difference(p＞0105).
Conclusion:
1.Ultra-podwer Wuji Pill can significantly improve clinical efficiency,Gastric mucosal area,regulate Serum levels of inflammatory factors,which shows it is an ideal anti-HP drugs.
2.Ultra-podwer Wuji Pill can fairly clear up HP which leads to gastric ulcer, reduced expression of IL-6,IL-8 and TNF-a.
方法:
1.按照中药新药临床研究要求,观察超微戊己丸对肝胃郁热型胃溃疡患者的临床疗效、胃镜检查、血清炎症因子IL-6、IL-8、TNF-a的影响。
2.采用Hp感染胃溃疡模型,随机分组,分别给药,分别采用ELASA、免疫组化检测IL-6、IL-8、TNF-a含量与表达
结果:
1.超微戊己丸对肝胃郁热型胃溃疡患者的临床疗效、中医证候疗效、胃镜疗效和Hp清除率分别为80.3%、90%、33.3%和66.7%,与传统戊己丸比较,差异无统计学意义(p>0.05)。
2.1/3剂量超微戊己丸能缩小HP感染致胃溃疡模型溃疡面积,与传统戊己丸全剂量组和三九胃泰组比较,差异无统计学意义(p>0.05),其能降低模型动物血清炎症因子IL-6、IL-8和TNF-a水平,下调TNF-a基因表达,与传统戊己丸、三九胃泰比较,差异无统计学意义(p>0.05)。
结论:
1.超微戊己丸能明显改善幽门螺杆菌致胃溃疡患者的临床症状,胃溃疡粘膜面积,调节血清炎症因子的水平,是较理想的针对肝胃郁热型胃溃疡的药物。
2.超微戊己丸能较好清除幽门螺杆菌致胃溃疡大鼠的幽门螺杆菌,明显下调IL-6、IL-8及TNF-a的表达。
Objective:To evaluate the clinical efficiency of ultra-podwer Wuji Pill on patients with gastric ulcer in syndrome of stomach and liver stagnation-hot,and discuss its effect on Anti-HP from expression of Inflammatory factors IL-6,IL-8 and TNF-a.
Methods:
1.According Chinese medicine clinical research in accordance with the requirements,evaluating the clinical efficiency,Gastroscopy result, Inflammatory factors IL-6,IL-8 and TNF-a of ultra-podwer Wuji Pill on patients with gastric ulcer in syndrome of stomach and liver stagnation-hot.
2.Using gastric ulcer model in Hp infection,animals were randomized, administrated respectively and detecting content and expression of IL-6,IL-8 and TNF-a by ELASA and Immunohistochemistry method.
Results:
1.Clinical efficiency,Syndrome efficiency,Gastroscopy effect and clearance rate of HP of ultra-podwer Wuji Pill on patients with gastric ulcer in syndrome of stomach and liver stagnation-hot was 80.3%.90%.33.3%and 66.7%,compared with traditional Wuji pill group,there was not significant difference(p＞0.05).
2.1/3 dosage ultra-podwer Wuji Pill group can narrow ulcer area of HP infected model,decrease expression of IL-6,IL-8 and TNF-a in rat model,which compared with traditional Wuji pill group and sanjiu weitai group,there was not significant difference(p＞0105).
Conclusion:
1.Ultra-podwer Wuji Pill can significantly improve clinical efficiency,Gastric mucosal area,regulate Serum levels of inflammatory factors,which shows it is an ideal anti-HP drugs.
2.Ultra-podwer Wuji Pill can fairly clear up HP which leads to gastric ulcer, reduced expression of IL-6,IL-8 and TNF-a.
引文
[1]危北海,张万岱,陈治水.中西医结合消化病学[M],北京:人民卫生出版社,2003年,第1版:363.
[2]余善强,周福生,崔琦珍等.溃疡愈合质量研究进展[J].华人消化杂志,1998:6(11):1010.
[3]伊藤诚.日本胃溃疡的治疗现状[M]/夏玉亭.胃病诊治进展.上海:上海科技教育出版社.2005:80.
[4]Wotherton J,Friedman GF,et al.Helieobaeter pylori assoeiated gastritis And Primary B-cell gastric lymphoma.Laneet 1991,338:1175.
[5]陈一,阎晓莉.幽门螺杆菌感染患儿血清IL-6、IL-8、IL-10水平变化[J].临床儿科杂志.2003,(21)3:163.
[6]张维,赵志泉,刘平,等.具有cagA基因的幽门螺杆菌感染与宿主产生白介素-8、肿瘤坏死因子-α的关系研究[J].中华消化杂志,2000,20(6):411.
[7]Blaster M.J,J Parsonnet,et al.parastism by the slow bacterium helieobaeter pylori leads to altered gastric homeostasis andneo Plasis.J ClinInvest 94:4.
[8]KA Thleen B,Shelita E,et al.Lymphoeytes in the human gastric mueosa during helieobacter Pylor ihave a TH cell.gastroenterology,1998,114:482.
[9]Pappo J,Kabok Z,et al.Reeombinant antigen prepred from the urease subunit of helieobaeter pylori:evidence of proteetion in mouse model of gstric infection.Infect Immun 1994,62:4981.
[10]张玫,汤哲.老年人消化性溃疡病与相关因素的影响[J].中华内科杂志,1998:37(10):702.
[11]宫海民,段文卓,孙思润,等.戊已丸对胃溃疡模型小鼠胃组织中前列腺素含量的影响[J].中国中医药科技.1999,6(2):124.
[12]蔡光先,杨永华,李跃辉,超微粉体技术与中药饮片改革[J].世界科学技术—中医药现代化.中药制剂,2004,6(2):67.
[13]陈灏珠.实用内科学[M].北京:人民卫生出版社.2005:525.
[14]王新月主编.普通高等教育“十一五”国家级规划教材《中医内科学》[M],北京: 高等教育出版社,2007,165.
[15]郑筱萸主编.《中药新药临床研究指导原则》[M],北京:中国医药科技出版社,2002214.
[16]田雪飞,范学工,张艳.C57BL/6小鼠幽门螺旋杆菌感染动物模型的建立[J].世界华人消化杂志,2004,12(6):1313.
[17]陈奇.中药药理研究方法学(第一版)[M],北京:人民卫生出版社,1994,457.
[18]姜泊.分子生物学常用实验方法[M].北京:人民军医出版社,1996:121.
[19]田德录,消化性溃疡研究评述[J].北京中医学院报,1991,14(6):15.
[20]李玲,姚军,孙英新,等.姚子扬胃溃疡从痈疮论治经验[J].山东中医杂志,1997,16(5):222.
[21]张学民.浅谈中医对胃溃疡的认识[J].河南中医学院学刊,河北中医药学刊,2000,12(4):50.
[22]郑继玄,胃及十二指肠溃疡的中医论治[J].医学创新研究,2008,5(11):119。
[23]杨倩,戴晓玲.抗溃疡中药粘膜保护作用的实验研究进展[J].河北中医,1995;17(1):48.
[24]宁学洪,宁学玲,黄馨仙,等.蒲葛舒胃灵对实验性胃溃疡作用的研究[J].中国药物与临床,2005,5(4):278.
[25]李春梅,梁代英,刘晋生,等.养阴颗粒治疗幽门螺杆菌感染实验性胃溃疡的实验研究[J].北京中医杂志,2002,21(5):309.
[26]何良志,张琼,王书臣.清胃止痛微丸治疗胃溃疡的临床研究fJ].中国中西医结合杂志,2001,21(6):422.
[27]王绪森,缴稳玲,吕宗舜,等.抑制幽门螺旋菌中药的初步筛选[J].中国中西医结合杂志,1994,14(9):534.
[28]张庆镐,朴惠善,李伟,等.关苍术复方颗粒对胃溃疡大鼠的影响[J].辽宁中医杂志,2005,32(7):737.
[29]黄志明,林军,陈美芳,等神曲胃痛片抗实验性胃溃疡作用的实验研究[J].中国药物应用与监测,2004,2:59.
[30]万清信,王燕,王德才,等.愈疡散治疗消化性溃疡的临床与实验研究[J].中国中西医结合杂志,1996,16(2):78.
[31]罗树星,李国成,熊伍军,等.健脾益气方对大鼠乙酸慢性胃溃疡的影响及其机制探 讨[J].同济医科大学学报1998,27(2):152.
[32]张向荣、潘卫东,胡军.丹参对消化性溃疡的研究概况.中草药,2000,31(8):附11.
[33]蔡亲福.黄连解毒汤和三黄泻心汤对大鼠胃黏膜的保护作用[J].日本药理学杂志,1991;4:319.
[34]洪缓,孟紫竿,侯家玉.柴胡汤、香砂六君子汤对胃粘膜保护作用的实验研究[J].北京中医药大学学报,1994;17(5):57.
[35]王汝俊,王建华,傅定中,等.补中益气汤的药理作用研究:抗实验性胃溃疡作用与机理[J].中药药理与临床,1991,7(5):1.
[36]易崇敬,叶百宽,金敬善,等.四君子汤对脾虚大鼠胃黏膜细胞酶组织化学及血浆胃肠激素的影响[J].北京中医药大学学报,1997,(6):31.
[37]邓兰琼,王国荣.柴胡桂枝汤对乙酸胃溃疡大鼠再生黏膜表层黏液的影响[J].中国中西医结合消化杂志,2005,13(4):243.
[38]杜鹏,薛洁,周承明,等.赤土获答普对实验性胃溃疡的保护作用[J].中草药,2000,31(4):277.
[39]胡玉兰,张忠义,王文婧,等.砂仁挥发油对大鼠乙酸性胃溃疡的影响及其机理探讨[J].中药材,2 005,28(11):1022.
[40]汪艳娟,王行宽,胡国恒.止血愈疡颗粒对幽门结扎型胃溃疡大鼠氧自由基参数的影响[J].中国中西医结合消化杂志,2002,10(4):206.
[41]郑继玄,胃及十二指肠溃疡的中医论治[J]。医学创新研究,2008,5(11):119.
[42]孟庆春.内科疑难病中医治疗学[M].北京:中医药出版社,2001,54.
[43]Zhou L,Sung JJ,Lin S,et al.A five year follow up study on the pathological change of gastric mucosa after H.pylori eradication[J].Chin med J,2003,116(1):11.
[44]王继德.HP的致病机制.[M].国外医学·消化系疾病分册,1994,14(1):14.
[45]李瑛,李家邦,陈军,等。HP感染与细胞凋亡和增殖、Fas/Fas1的关系[J].世界华人消化杂志,2001,9(12):1404.
[46]BEIL W,ENSS ML,MULLER S,et al.Role of VacA and CagA in Helicobacter,Pylori Inhibition of Mucin Synthesis.in Gastric mucosal Cells.J Clin Microbiol,2000,38:2215.
[47]刘晓君,杜雅菊,沈滨.幽门螺杆菌cagA基因与胃上皮细胞凋亡、增生的关系[J].世界华人消化杂志,2005,13:246.
[48]ASHORN M,CANTET F,MAYO K,et al.Cytoskeletal Rearrangement sinduced by Helicobacter Pylori Strains in Epithelial Cell Cul-ture:Possible Role of the Cytotoxin.Dig Dis Sci,2000,45:1774.
[49]TOMBOLA F,DEL GIUDICE G,PAPINI E,et al.Blockers of VacA Provide Insights into the Structure of the Pore.Biophys J.2000,79:863.
[50]Uunt RH.Scand J GastIDenterol,Ando T,Kusugami K,Ohsuga M,et al.Interleukin-8 activity correlates with histological severity in neli-cobacter pylori-associated antral gastritis.Am J Gastroenterol,1996Jun;91:1150.
[51]Ando T,Kusugami K,Ohsuga M,et al.Interleukin-8 activity correlates with histological severity in Heli-cobacter pylori-associated antral gastritis.Am J Gastroenterol,1996 Jun;91:1150.
[52]周福生,胡丽娟,王汝俊 健脾清热化痰方对胃溃疡患者T细胞亚群及IL-8的影响[J].上海中医药大学学报,2006,20(2):18.
[53]Crabtree JE,Shallcross TM,Heatley RV,et al.Mucosal tumour necrosis factor and interleukin-6 in patientswith Helicobacter pylori associated gastritis.Gut,1991;32:1473.
[54]Furukawa K.The enhanced expression of IL-6 and 8MRNA in UP-Positive gastric ulcer.Gastroeuterol 1995;(Suppll4):A9.
[55]Ginchetti P,Vaira D,CamPier M,et al.enhanced mucosal interleukin-6 and -8 in Hilicobacter Pylori Positive dysoepic patients.Am J Gastroenterol 1994;89:883.
[56]张维,赵志泉.IL-8、TNF-α在Hp感染中的作用研究[J].胃肠病学和肝病学杂志.2000(9)4:270.
[57]Van Deventer SJH,Hart M,van der poll T,et al.Endotoxin and tumour necrmis factor-α induced interleukin-8 release in lumnans.J Infest Pis,1993.167(2):461.
[58]张珺,赵清喜.肿瘤坏死因子、白介素8和细胞问粘附分子1在溃疡性结肠炎患者 外周血中的表达及其·临床意义[J].社区医学杂志,2007,(5)19:56.
[59]周茂鲁,刘淑华.戊己丸加减合西药治疗消化性溃疡38例临床观察[J].中华实用中西医杂志,2007,20(23):2056-2057.
[60]陈峰.中西医结合治疗幽门螺杆菌相关性消化性溃疡疗效观察[J].中华实用中西医杂志,2004,4(2):175.
[61]王娅杰,董宇.戊己丸提取物不同配伍方对豚鼠离体结肠运动影响的实验研究[J].中国中药杂志,2007(32)20:2161。
[62]唐小梅,伍参荣.戊己水煎液对幽门螺杆菌诱导SGC-7901细胞分泌白细胞介素-8的作用[J].中国中医药信息杂志.2008,15(8):43-45.
[63]伍参荣,彭程.戊己丸水煎液对幽门螺旋杆菌感染小鼠体内NO含量的影响[J].中医药导报,2006(12)1:65-66.
[64]唐小梅,伍参荣.戊己水煎液对幽门螺杆菌感染胃上皮细胞凋亡的作用.中华中医药学刊.2007,25(11):2365-2367.
[65]唐小梅,伍参荣,田雪飞.戊己水煎液在体外对幽门螺杆菌的抑制作用[J],中医药学刊.2005,23(4):703-704.
[66]唐小梅,伍参荣.戊己水煎液对幽门螺杆菌感染胃上皮细胞的保护作用[J].中医药学刊.2005,23(9):1688-1691.
[67]张穗坚,谢国采.常用中草药手册[M].广州:广东高等教育出版社,1997,82。
[68]孟庆玲.奥美拉唑与黄连素联合治疗消化性溃疡及根除幽门螺杆菌的疗效观察[J].现代中西医结合杂志.2002,11(12):2450.
[69]Li XK,MotwaniM,TongW,et al.Huanglian,A Chine-herbal extract,in-hibits cell growth by suppressing the expressing of cyelin BI and inhibiting CDC2kinase activity in human cancer cells.Mol Pharmacol,2000,58(6):1287-1293.
[70]郭玉文,夏素青.黄连素治疗消化性溃疡32例[J].安徽医科大学学报.1997,32(4)。
[71]魏宁,张松伟.吴茱萸对消化系统药理作用研究[J].空军总医院学报,2004,20(1):49。
[72]HartChieh Ko,Yea Hwey Wang,Kuo-Tong Liou,et al.Anti—inflamnmtory efects and mechanisms of the cthanol extract of Evodia rutaecarpaand its bioactive components on neutrophils and microgliat ceHs.Europen Joural of Pharmacolog 2007,48(21)555.
[73]Matsuda H,Wu JX,Tanaka T,et al.Antinociceptive activities of 70%methanol extract of evodiae fructusand its alkaloidal components.Biol JP.rm Bulf,1997,20(3):243.
[74]Lin H,Tsai SC,Chen JJ,et al.Effects of evodiamine on the secretion of testosterone in rat testicular interstitial cells.Metabolism,1999,48(12):1532.
[75]覃俊佳,覃平,罗宇东,等.白芍泻下作用机理的实验研究[J].中国中医药科技,19985(3):155.
[76]高崇凯,吴雁,王勇,等.白芍总苷粉针剂的抗炎镇痛作用[J].中国新药药理与临床药理,2002,3:25.
[77]候连兵等.中药细胞级微粉碎技术在中药药剂中的应用[J].中药材,2001,10:765.
[78]蔡光先,杨永华,李跃辉,等.世界科学技术—中医药现代化[J].中药制剂,2004.6(2):67.
[79]许启泰,杜钢军,包翠屏,等.复方地黄超细微粉药理学研究.中草药,2002,6:537.
[1]Hunt RH.Scand J Gastroenterol,1996;31(Supp1220):3.
[2]Tham KT,Peek RJ,AthertonJC,et al.Helicobacterpylori genotypes,host factors,and gastric mucosal histopathology in pepticulcer disease[J].Hum Pathol,2001,32(3):264.
[3]肖健存,王莲香,王尔奇,等.幽门螺杆菌在胃与十二指肠疾病中的检出率及其分布[J].北京医学,2001,23(3):185.
[4]周丽雅,沈祖尧,林三仁,等.根除幽门螺杆菌对胃黏膜炎症变化的人群随访研究[J].中华内科杂志,2003,42(3):162.
[5]王吉耀,王瑞娟,徐永正,等.幽门螺杆菌感染对胃黏膜病理变化的影响[J].胃肠病学,2003,8(1):25.
[6]Fichman,Suzana l,Yaron N.Histological changes in the gastric mucosa after Helicobacter pylori eradication[J].Eur J Gastroenterol Hepatol,2004,16(11):1183.
[7]Crabtree JE,Shallcross TM,Heatley RV,et al.Mucosal tumour necrosis factor alpha and interleukin-6 in patientswith Helicobacter pylori associated gastritis[J].Gut,1991,32(12):1473.
[8]Gionchetti P,Vaira D,CampieriM,et al.Enhanced mucosal interleukin-6 and-8 in Helicobacter pylori-positive dyspeptic patients[J].Am J Gastroenterol,1994,89(6):883.
[9]Lindbolm L,Quiding CM,Lonrith H,et al.Local cytokine response in helicobacter pylori infected subject[J].Infect Immune,1998,66(12):5964.
[10]Yashimma T,Matsushima K,OppenheimJJ et al.[J]Immunol,1987;139:788.
[11]Sasayama Y,Kawano S,Tsuji S et al.J GastroenterolHepatol,1997;12(2):104.
[12]Uemura N,Oomoto Y,Mukai T et al.Aliment Pharmacol Ther,1997;11(4):793.
[13]陈晓,翁志华,贺立,等.胃黏膜IL-8、G-CSF含量的变化与幽门螺杆菌感染的关系[J].医学临床研究,2005,22(12):1665.
[14]Suzuki T,Ina K,Nishiwali T,at el.Differential rules of interleukin-1 beta and interleukin-8in neutrophil transendothelial migration in patients with Helicobater pylori infection[J].scand Gastroenterol,2004,39:313.
[15]张尤历,华晔,杨大明.幽门螺杆菌相关性慢性胃炎及消化性溃疡胃黏膜白细胞介素8的表达[J].中华消化内镜杂志,2005,22(4):274.
[16]Crabtree J E.Scand J Gastroenterol,1996;31(Supp1215):3.
[17]Martin Guerrero JM,Hergueta Delgado P,Eateban Carreter J J,et al.Pathogenic implications of interleukin-8 activity and bacterial phenotype in antral gastritias associated with Helicobater pylori[J].Rev Esp Enferm Dig.2000,92:301.
[18]Kim JM,Kim JS,Jung HC,et al.Virulence factors of Helicobacter pylori in Korean isolates do not influence proinflammatory cytokine gene expression and apoptosis in human gastric epithelial cells,nor do these factors influence the clinical outcome[J].Gastroenterol,2000,35:898.
[19]Brandt S,Kwok T,Hartig R,et al.NF-κB activation andpotentiation of proinflammatory responses by the Helicobacter pylori CagA protein[J].Proc Natl Acad Sci,2005,102(26):9300.
[20]Takenaka R,Yokota K,Ayada K,et al.Helicobacter pyloriheat-shock protein 60 induces inflammatory responses throughthe Toll-like receptor-triggered pathway in cultured human gastric epithelial cells[J].Microbiology,2004,150(12):3913.
[21]Seo JH,Lim JW,Kim H,et al.Helicobacter pylori in a Korean isolate activates mitogen-activated protein kinases,AP-1,and NF-κB and induces chemoldne expression in gastric epithelialAGS cells[J].Lab Invest,2004,84(1):49.
[22]Kim JM,Kim JS,Jung HC,et al.Inhibition of Helicobacter pylori-induced nuclear factor-κB activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells[J].Helicobacter,2003,8(5):542.
[23]Bhattacharyya A,Pathak S,Datta S,et al.Mitogen-activated protein kinases and nuclear factor-κB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages[J].Biochem J,2002,368:121.
[24]Watanabe T,Higuchi K,Hamaguchi M,et al.Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-α[J].Am J Physiol Gastrointest Liver Physiol,2004,287(4):919.
[25]Watanabe T,Higuchi K,Tominaga K,et al.Acid regulates inammatory response in a ratmodelof inductionof gastric ulcer recurrence by interleukin 1[J].Gut,2001,48(6):774.
[26]张力超 中药治疗幽门螺旋杆菌感染近况[J].实用中西药结合杂志,1992,4(5):237.
[27]蒋振明 徐国缨.中药复方对幽门螺旋菌作用的体外实验[J].中国中医结合消化杂志,2001,9(2):101.
[28]李臻,魏宝永.左金丸在治疗幽门螺旋杆菌感染性胃病中的应用[J].中华实用中医杂志,2005,18(5):725.
[29]张宏.黄芪注射液治疗消化性溃疡[J],医药论坛杂志,2005,26(14):78.
[30]万里飞,徐燮忠,张亮等.刺五加注射液治疗复合性溃疡临床观察[J],华夏医学,2003,16(4):478.
[31]张富山,孙国善.自拟疡愈汤配合穴位注射治疗消化性溃疡临床观察[J],河南中医学院学报,2003,1(1):49.
[32]王华鄂,韦之平,黎瑞康等.乌贼八味散合654-2穴位注射治疗消化性溃疡疗效观察[J],华夏医学,2003,13(6):807.
[33]王丙信,杨同占,吕玉洁等.幽门中西医结合疗法治疗幽门螺杆菌阳性消化性溃疡的远期疗效观察[J].中国中西医结合消化杂志,2001,9(1):23.
[34]游小苇,李翠红,童昌珍.半夏泻心汤合法莫替丁预防消化性溃疡复发的临床观察[J].中医药导报,2006,12(3):19.
[35]叶雪萍.健胃散抗消化性溃疡复发作用的临床观察[J].河北中医,2004,26(2):101.
[36]周继鹏。黄连公英汤治疗慢性胃炎100例[J].陕西中医,2005,26(9):909-910.
[37]金涛,乔玉山,游运舸.愈溃合剂治疗幽门螺杆菌相关性消化性溃疡50例临床观察[J].中医药导报,2007,13(2):32-33.
[38]万昌俭.香砂左金丸治疗消化性溃疡42例[J].山西中医,2007,23(1):20.
[39]许新文,倪玉梅.健脾理气法治疗消化性溃疡36例[J].陕西中医,2007,28(1):33.
[2]余善强,周福生,崔琦珍等.溃疡愈合质量研究进展[J].华人消化杂志,1998:6(11):1010.
[3]伊藤诚.日本胃溃疡的治疗现状[M]/夏玉亭.胃病诊治进展.上海:上海科技教育出版社.2005:80.
[4]Wotherton J,Friedman GF,et al.Helieobaeter pylori assoeiated gastritis And Primary B-cell gastric lymphoma.Laneet 1991,338:1175.
[5]陈一,阎晓莉.幽门螺杆菌感染患儿血清IL-6、IL-8、IL-10水平变化[J].临床儿科杂志.2003,(21)3:163.
[6]张维,赵志泉,刘平,等.具有cagA基因的幽门螺杆菌感染与宿主产生白介素-8、肿瘤坏死因子-α的关系研究[J].中华消化杂志,2000,20(6):411.
[7]Blaster M.J,J Parsonnet,et al.parastism by the slow bacterium helieobaeter pylori leads to altered gastric homeostasis andneo Plasis.J ClinInvest 94:4.
[8]KA Thleen B,Shelita E,et al.Lymphoeytes in the human gastric mueosa during helieobacter Pylor ihave a TH cell.gastroenterology,1998,114:482.
[9]Pappo J,Kabok Z,et al.Reeombinant antigen prepred from the urease subunit of helieobaeter pylori:evidence of proteetion in mouse model of gstric infection.Infect Immun 1994,62:4981.
[10]张玫,汤哲.老年人消化性溃疡病与相关因素的影响[J].中华内科杂志,1998:37(10):702.
[11]宫海民,段文卓,孙思润,等.戊已丸对胃溃疡模型小鼠胃组织中前列腺素含量的影响[J].中国中医药科技.1999,6(2):124.
[12]蔡光先,杨永华,李跃辉,超微粉体技术与中药饮片改革[J].世界科学技术—中医药现代化.中药制剂,2004,6(2):67.
[13]陈灏珠.实用内科学[M].北京:人民卫生出版社.2005:525.
[14]王新月主编.普通高等教育“十一五”国家级规划教材《中医内科学》[M],北京: 高等教育出版社,2007,165.
[15]郑筱萸主编.《中药新药临床研究指导原则》[M],北京:中国医药科技出版社,2002214.
[16]田雪飞,范学工,张艳.C57BL/6小鼠幽门螺旋杆菌感染动物模型的建立[J].世界华人消化杂志,2004,12(6):1313.
[17]陈奇.中药药理研究方法学(第一版)[M],北京:人民卫生出版社,1994,457.
[18]姜泊.分子生物学常用实验方法[M].北京:人民军医出版社,1996:121.
[19]田德录,消化性溃疡研究评述[J].北京中医学院报,1991,14(6):15.
[20]李玲,姚军,孙英新,等.姚子扬胃溃疡从痈疮论治经验[J].山东中医杂志,1997,16(5):222.
[21]张学民.浅谈中医对胃溃疡的认识[J].河南中医学院学刊,河北中医药学刊,2000,12(4):50.
[22]郑继玄,胃及十二指肠溃疡的中医论治[J].医学创新研究,2008,5(11):119。
[23]杨倩,戴晓玲.抗溃疡中药粘膜保护作用的实验研究进展[J].河北中医,1995;17(1):48.
[24]宁学洪,宁学玲,黄馨仙,等.蒲葛舒胃灵对实验性胃溃疡作用的研究[J].中国药物与临床,2005,5(4):278.
[25]李春梅,梁代英,刘晋生,等.养阴颗粒治疗幽门螺杆菌感染实验性胃溃疡的实验研究[J].北京中医杂志,2002,21(5):309.
[26]何良志,张琼,王书臣.清胃止痛微丸治疗胃溃疡的临床研究fJ].中国中西医结合杂志,2001,21(6):422.
[27]王绪森,缴稳玲,吕宗舜,等.抑制幽门螺旋菌中药的初步筛选[J].中国中西医结合杂志,1994,14(9):534.
[28]张庆镐,朴惠善,李伟,等.关苍术复方颗粒对胃溃疡大鼠的影响[J].辽宁中医杂志,2005,32(7):737.
[29]黄志明,林军,陈美芳,等神曲胃痛片抗实验性胃溃疡作用的实验研究[J].中国药物应用与监测,2004,2:59.
[30]万清信,王燕,王德才,等.愈疡散治疗消化性溃疡的临床与实验研究[J].中国中西医结合杂志,1996,16(2):78.
[31]罗树星,李国成,熊伍军,等.健脾益气方对大鼠乙酸慢性胃溃疡的影响及其机制探 讨[J].同济医科大学学报1998,27(2):152.
[32]张向荣、潘卫东,胡军.丹参对消化性溃疡的研究概况.中草药,2000,31(8):附11.
[33]蔡亲福.黄连解毒汤和三黄泻心汤对大鼠胃黏膜的保护作用[J].日本药理学杂志,1991;4:319.
[34]洪缓,孟紫竿,侯家玉.柴胡汤、香砂六君子汤对胃粘膜保护作用的实验研究[J].北京中医药大学学报,1994;17(5):57.
[35]王汝俊,王建华,傅定中,等.补中益气汤的药理作用研究:抗实验性胃溃疡作用与机理[J].中药药理与临床,1991,7(5):1.
[36]易崇敬,叶百宽,金敬善,等.四君子汤对脾虚大鼠胃黏膜细胞酶组织化学及血浆胃肠激素的影响[J].北京中医药大学学报,1997,(6):31.
[37]邓兰琼,王国荣.柴胡桂枝汤对乙酸胃溃疡大鼠再生黏膜表层黏液的影响[J].中国中西医结合消化杂志,2005,13(4):243.
[38]杜鹏,薛洁,周承明,等.赤土获答普对实验性胃溃疡的保护作用[J].中草药,2000,31(4):277.
[39]胡玉兰,张忠义,王文婧,等.砂仁挥发油对大鼠乙酸性胃溃疡的影响及其机理探讨[J].中药材,2 005,28(11):1022.
[40]汪艳娟,王行宽,胡国恒.止血愈疡颗粒对幽门结扎型胃溃疡大鼠氧自由基参数的影响[J].中国中西医结合消化杂志,2002,10(4):206.
[41]郑继玄,胃及十二指肠溃疡的中医论治[J]。医学创新研究,2008,5(11):119.
[42]孟庆春.内科疑难病中医治疗学[M].北京:中医药出版社,2001,54.
[43]Zhou L,Sung JJ,Lin S,et al.A five year follow up study on the pathological change of gastric mucosa after H.pylori eradication[J].Chin med J,2003,116(1):11.
[44]王继德.HP的致病机制.[M].国外医学·消化系疾病分册,1994,14(1):14.
[45]李瑛,李家邦,陈军,等。HP感染与细胞凋亡和增殖、Fas/Fas1的关系[J].世界华人消化杂志,2001,9(12):1404.
[46]BEIL W,ENSS ML,MULLER S,et al.Role of VacA and CagA in Helicobacter,Pylori Inhibition of Mucin Synthesis.in Gastric mucosal Cells.J Clin Microbiol,2000,38:2215.
[47]刘晓君,杜雅菊,沈滨.幽门螺杆菌cagA基因与胃上皮细胞凋亡、增生的关系[J].世界华人消化杂志,2005,13:246.
[48]ASHORN M,CANTET F,MAYO K,et al.Cytoskeletal Rearrangement sinduced by Helicobacter Pylori Strains in Epithelial Cell Cul-ture:Possible Role of the Cytotoxin.Dig Dis Sci,2000,45:1774.
[49]TOMBOLA F,DEL GIUDICE G,PAPINI E,et al.Blockers of VacA Provide Insights into the Structure of the Pore.Biophys J.2000,79:863.
[50]Uunt RH.Scand J GastIDenterol,Ando T,Kusugami K,Ohsuga M,et al.Interleukin-8 activity correlates with histological severity in neli-cobacter pylori-associated antral gastritis.Am J Gastroenterol,1996Jun;91:1150.
[51]Ando T,Kusugami K,Ohsuga M,et al.Interleukin-8 activity correlates with histological severity in Heli-cobacter pylori-associated antral gastritis.Am J Gastroenterol,1996 Jun;91:1150.
[52]周福生,胡丽娟,王汝俊 健脾清热化痰方对胃溃疡患者T细胞亚群及IL-8的影响[J].上海中医药大学学报,2006,20(2):18.
[53]Crabtree JE,Shallcross TM,Heatley RV,et al.Mucosal tumour necrosis factor and interleukin-6 in patientswith Helicobacter pylori associated gastritis.Gut,1991;32:1473.
[54]Furukawa K.The enhanced expression of IL-6 and 8MRNA in UP-Positive gastric ulcer.Gastroeuterol 1995;(Suppll4):A9.
[55]Ginchetti P,Vaira D,CamPier M,et al.enhanced mucosal interleukin-6 and -8 in Hilicobacter Pylori Positive dysoepic patients.Am J Gastroenterol 1994;89:883.
[56]张维,赵志泉.IL-8、TNF-α在Hp感染中的作用研究[J].胃肠病学和肝病学杂志.2000(9)4:270.
[57]Van Deventer SJH,Hart M,van der poll T,et al.Endotoxin and tumour necrmis factor-α induced interleukin-8 release in lumnans.J Infest Pis,1993.167(2):461.
[58]张珺,赵清喜.肿瘤坏死因子、白介素8和细胞问粘附分子1在溃疡性结肠炎患者 外周血中的表达及其·临床意义[J].社区医学杂志,2007,(5)19:56.
[59]周茂鲁,刘淑华.戊己丸加减合西药治疗消化性溃疡38例临床观察[J].中华实用中西医杂志,2007,20(23):2056-2057.
[60]陈峰.中西医结合治疗幽门螺杆菌相关性消化性溃疡疗效观察[J].中华实用中西医杂志,2004,4(2):175.
[61]王娅杰,董宇.戊己丸提取物不同配伍方对豚鼠离体结肠运动影响的实验研究[J].中国中药杂志,2007(32)20:2161。
[62]唐小梅,伍参荣.戊己水煎液对幽门螺杆菌诱导SGC-7901细胞分泌白细胞介素-8的作用[J].中国中医药信息杂志.2008,15(8):43-45.
[63]伍参荣,彭程.戊己丸水煎液对幽门螺旋杆菌感染小鼠体内NO含量的影响[J].中医药导报,2006(12)1:65-66.
[64]唐小梅,伍参荣.戊己水煎液对幽门螺杆菌感染胃上皮细胞凋亡的作用.中华中医药学刊.2007,25(11):2365-2367.
[65]唐小梅,伍参荣,田雪飞.戊己水煎液在体外对幽门螺杆菌的抑制作用[J],中医药学刊.2005,23(4):703-704.
[66]唐小梅,伍参荣.戊己水煎液对幽门螺杆菌感染胃上皮细胞的保护作用[J].中医药学刊.2005,23(9):1688-1691.
[67]张穗坚,谢国采.常用中草药手册[M].广州:广东高等教育出版社,1997,82。
[68]孟庆玲.奥美拉唑与黄连素联合治疗消化性溃疡及根除幽门螺杆菌的疗效观察[J].现代中西医结合杂志.2002,11(12):2450.
[69]Li XK,MotwaniM,TongW,et al.Huanglian,A Chine-herbal extract,in-hibits cell growth by suppressing the expressing of cyelin BI and inhibiting CDC2kinase activity in human cancer cells.Mol Pharmacol,2000,58(6):1287-1293.
[70]郭玉文,夏素青.黄连素治疗消化性溃疡32例[J].安徽医科大学学报.1997,32(4)。
[71]魏宁,张松伟.吴茱萸对消化系统药理作用研究[J].空军总医院学报,2004,20(1):49。
[72]HartChieh Ko,Yea Hwey Wang,Kuo-Tong Liou,et al.Anti—inflamnmtory efects and mechanisms of the cthanol extract of Evodia rutaecarpaand its bioactive components on neutrophils and microgliat ceHs.Europen Joural of Pharmacolog 2007,48(21)555.
[73]Matsuda H,Wu JX,Tanaka T,et al.Antinociceptive activities of 70%methanol extract of evodiae fructusand its alkaloidal components.Biol JP.rm Bulf,1997,20(3):243.
[74]Lin H,Tsai SC,Chen JJ,et al.Effects of evodiamine on the secretion of testosterone in rat testicular interstitial cells.Metabolism,1999,48(12):1532.
[75]覃俊佳,覃平,罗宇东,等.白芍泻下作用机理的实验研究[J].中国中医药科技,19985(3):155.
[76]高崇凯,吴雁,王勇,等.白芍总苷粉针剂的抗炎镇痛作用[J].中国新药药理与临床药理,2002,3:25.
[77]候连兵等.中药细胞级微粉碎技术在中药药剂中的应用[J].中药材,2001,10:765.
[78]蔡光先,杨永华,李跃辉,等.世界科学技术—中医药现代化[J].中药制剂,2004.6(2):67.
[79]许启泰,杜钢军,包翠屏,等.复方地黄超细微粉药理学研究.中草药,2002,6:537.
[1]Hunt RH.Scand J Gastroenterol,1996;31(Supp1220):3.
[2]Tham KT,Peek RJ,AthertonJC,et al.Helicobacterpylori genotypes,host factors,and gastric mucosal histopathology in pepticulcer disease[J].Hum Pathol,2001,32(3):264.
[3]肖健存,王莲香,王尔奇,等.幽门螺杆菌在胃与十二指肠疾病中的检出率及其分布[J].北京医学,2001,23(3):185.
[4]周丽雅,沈祖尧,林三仁,等.根除幽门螺杆菌对胃黏膜炎症变化的人群随访研究[J].中华内科杂志,2003,42(3):162.
[5]王吉耀,王瑞娟,徐永正,等.幽门螺杆菌感染对胃黏膜病理变化的影响[J].胃肠病学,2003,8(1):25.
[6]Fichman,Suzana l,Yaron N.Histological changes in the gastric mucosa after Helicobacter pylori eradication[J].Eur J Gastroenterol Hepatol,2004,16(11):1183.
[7]Crabtree JE,Shallcross TM,Heatley RV,et al.Mucosal tumour necrosis factor alpha and interleukin-6 in patientswith Helicobacter pylori associated gastritis[J].Gut,1991,32(12):1473.
[8]Gionchetti P,Vaira D,CampieriM,et al.Enhanced mucosal interleukin-6 and-8 in Helicobacter pylori-positive dyspeptic patients[J].Am J Gastroenterol,1994,89(6):883.
[9]Lindbolm L,Quiding CM,Lonrith H,et al.Local cytokine response in helicobacter pylori infected subject[J].Infect Immune,1998,66(12):5964.
[10]Yashimma T,Matsushima K,OppenheimJJ et al.[J]Immunol,1987;139:788.
[11]Sasayama Y,Kawano S,Tsuji S et al.J GastroenterolHepatol,1997;12(2):104.
[12]Uemura N,Oomoto Y,Mukai T et al.Aliment Pharmacol Ther,1997;11(4):793.
[13]陈晓,翁志华,贺立,等.胃黏膜IL-8、G-CSF含量的变化与幽门螺杆菌感染的关系[J].医学临床研究,2005,22(12):1665.
[14]Suzuki T,Ina K,Nishiwali T,at el.Differential rules of interleukin-1 beta and interleukin-8in neutrophil transendothelial migration in patients with Helicobater pylori infection[J].scand Gastroenterol,2004,39:313.
[15]张尤历,华晔,杨大明.幽门螺杆菌相关性慢性胃炎及消化性溃疡胃黏膜白细胞介素8的表达[J].中华消化内镜杂志,2005,22(4):274.
[16]Crabtree J E.Scand J Gastroenterol,1996;31(Supp1215):3.
[17]Martin Guerrero JM,Hergueta Delgado P,Eateban Carreter J J,et al.Pathogenic implications of interleukin-8 activity and bacterial phenotype in antral gastritias associated with Helicobater pylori[J].Rev Esp Enferm Dig.2000,92:301.
[18]Kim JM,Kim JS,Jung HC,et al.Virulence factors of Helicobacter pylori in Korean isolates do not influence proinflammatory cytokine gene expression and apoptosis in human gastric epithelial cells,nor do these factors influence the clinical outcome[J].Gastroenterol,2000,35:898.
[19]Brandt S,Kwok T,Hartig R,et al.NF-κB activation andpotentiation of proinflammatory responses by the Helicobacter pylori CagA protein[J].Proc Natl Acad Sci,2005,102(26):9300.
[20]Takenaka R,Yokota K,Ayada K,et al.Helicobacter pyloriheat-shock protein 60 induces inflammatory responses throughthe Toll-like receptor-triggered pathway in cultured human gastric epithelial cells[J].Microbiology,2004,150(12):3913.
[21]Seo JH,Lim JW,Kim H,et al.Helicobacter pylori in a Korean isolate activates mitogen-activated protein kinases,AP-1,and NF-κB and induces chemoldne expression in gastric epithelialAGS cells[J].Lab Invest,2004,84(1):49.
[22]Kim JM,Kim JS,Jung HC,et al.Inhibition of Helicobacter pylori-induced nuclear factor-κB activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells[J].Helicobacter,2003,8(5):542.
[23]Bhattacharyya A,Pathak S,Datta S,et al.Mitogen-activated protein kinases and nuclear factor-κB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages[J].Biochem J,2002,368:121.
[24]Watanabe T,Higuchi K,Hamaguchi M,et al.Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-α[J].Am J Physiol Gastrointest Liver Physiol,2004,287(4):919.
[25]Watanabe T,Higuchi K,Tominaga K,et al.Acid regulates inammatory response in a ratmodelof inductionof gastric ulcer recurrence by interleukin 1[J].Gut,2001,48(6):774.
[26]张力超 中药治疗幽门螺旋杆菌感染近况[J].实用中西药结合杂志,1992,4(5):237.
[27]蒋振明 徐国缨.中药复方对幽门螺旋菌作用的体外实验[J].中国中医结合消化杂志,2001,9(2):101.
[28]李臻,魏宝永.左金丸在治疗幽门螺旋杆菌感染性胃病中的应用[J].中华实用中医杂志,2005,18(5):725.
[29]张宏.黄芪注射液治疗消化性溃疡[J],医药论坛杂志,2005,26(14):78.
[30]万里飞,徐燮忠,张亮等.刺五加注射液治疗复合性溃疡临床观察[J],华夏医学,2003,16(4):478.
[31]张富山,孙国善.自拟疡愈汤配合穴位注射治疗消化性溃疡临床观察[J],河南中医学院学报,2003,1(1):49.
[32]王华鄂,韦之平,黎瑞康等.乌贼八味散合654-2穴位注射治疗消化性溃疡疗效观察[J],华夏医学,2003,13(6):807.
[33]王丙信,杨同占,吕玉洁等.幽门中西医结合疗法治疗幽门螺杆菌阳性消化性溃疡的远期疗效观察[J].中国中西医结合消化杂志,2001,9(1):23.
[34]游小苇,李翠红,童昌珍.半夏泻心汤合法莫替丁预防消化性溃疡复发的临床观察[J].中医药导报,2006,12(3):19.
[35]叶雪萍.健胃散抗消化性溃疡复发作用的临床观察[J].河北中医,2004,26(2):101.
[36]周继鹏。黄连公英汤治疗慢性胃炎100例[J].陕西中医,2005,26(9):909-910.
[37]金涛,乔玉山,游运舸.愈溃合剂治疗幽门螺杆菌相关性消化性溃疡50例临床观察[J].中医药导报,2007,13(2):32-33.
[38]万昌俭.香砂左金丸治疗消化性溃疡42例[J].山西中医,2007,23(1):20.
[39]许新文,倪玉梅.健脾理气法治疗消化性溃疡36例[J].陕西中医,2007,28(1):33.